Tech Company Financing Transactions
MatriSys Bioscience Funding Round
MatriSys Bioscience, based in La Jolla, raised $1.5 million from Tech Coast Angels and private investors.
Transaction Overview
Company Name
Announced On
1/7/2017
Transaction Type
Venture Equity
Amount
$1,500,000
Round
Undisclosed
Investors
Tech Coast Angels (Lead Investor) (Jeff Friedman)
Proceeds Purpose
This round of funding will be used to support and accelerate clinical trials for atopic dermatitis and continue preclinical work to support MatriSys' growing pipeline of live biologic therapeutics for additional clinical indications.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
505 Coast Blvd. South 311
La Jolla, CA 92037
USA
La Jolla, CA 92037
USA
Phone
Website
Email Address
Overview
MatriSys Bioscience (MatriSys Bio) is a clinical stage Specialty Biopharmaceutical Company focused on developing and commercializing rational microbiome therapies for the top five dermatology and skin care conditions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Wilson
Browse more venture capital transactions:
Prev: 1/7/2017: Microbion venture capital transaction
Next: 1/7/2017: Blue Pillar venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC transactions reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs